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Evaluation of Purine Salvage as a Chemotherapeutic Target in the Plasmodium yoelii Rodent Model W81XWH-05-2-0025 Kami Kim, MD
Introduction:
Because resistance to current antimalarials is widespread, new targets for malaria chemotherapy are needed to protect military personnel stationed in developing countries. Malaria parasites cannot make purines needed for RNA and DNA and must salvage purines from their host. Our preliminary studies reveal purine salvage is unique in malaria parasites. We would like to determine whether the unique activities of the malaria enzymes can be exploited to develop specific treatments for malaria that will be effective but not toxic. While study of drug targets in vivo is critical for all infectious diseases, evaluation in an animal model is especially critical for evaluation of purine salvage as a drug target. Malaria parasites are routinely maintained in the laboratory with high concentrations of purines, but levels of purines in mammalian blood are tightly regulated and 100-fold less than typical culture conditions. Therefore the efficacy of purine salvage inhibition and importance of purine salvage enzymes must be examined under physiological conditions that cannot be replicated during in vitro culture conditions. We plan to perform our studies in Plasmodium yoelii, a rodent malaria whose genome has been sequenced and for which there are techniques for genetic manipulation. Using this system we will genetically disrupt purine salvage genes and test their importance to the parasite. We will test the effects of malaria-specific purine salvage inhibitors on malaria infection in mice. These novel drugs will be tested in combination with other antimalarials and will also be evaluated for efficacy against exoerythrocytic malaria forms. We hope these experiments will lead to the development of new effective and nontoxic agents that can protect our military personnel from the lethal effects of malaria infection.
Task 1 PNP gene disruption in Plasmodium yoelii.
1. Make double cross-over constructs for PyPNP including one that replaces P. falciparum PNP for PyPNP. Months 1-3, year 1 2. Transfect, select and clone disruptants in mice. Months 4-12 year 1. 3. Analyze phenotype of disruptants and PfPNP replacements for mouse virulence, ability to complete the full life cycle, ability to transport and incorporate purines. Year 1 and year 2.
We have completed most of this task. Our manuscript describing our findings with the pypnp parasites is now in revision. As discussed in our revised progress report for 2007, these parasites are attenuated in blood stages and unable to make oocysts in mosquitoes. Mice administered the attenuated parasites are protected from subsequent lethal challenge. See figure 1 below, from our prior progress report. We are further investigating the virulence of these attenuated pypnp parasites in immunocompromised mice. It is possible that these parasites can be used for development as asexual stage attenuated vaccines similar to the attenuated sporozoites proposed by others. After the fate of the submitted manuscript is decided we will write a methods paper delineating our improved protocols for genetic manipulation of Plasmodium yoelii parasites. We have used this methodology for other studies in P. yoelii and a manuscript on disruption of Pyhmgb2 has been accepted to JBC. Dr. Ting, lead personnel on this grant, assisted in the early studies for this manuscript.
Task 2 ADA disruption in
Plasmodium yoelii.
1. Make single and double cross-over disruption constructs. Months 10-12, year 1 2. Transfect, select and clone disruptants. Months 1-6, year 2. 3. Analyze phenotype of disruptants for mouse virulence, ability to complete the full life cycle, ability to transport and incorporate purines. Months 7-12 year 2. Continue year 3
We have nearly completed this aim. After our successful development of double crossover gene deletion methodology for disruption of Pypnp (see aim 1), we were able to quickly delete the PyADA gene. Surprisingly, in contrast to pypnp parasites, pyada parasites are not significantly attenuated. We are repeating studies to have statistically robust numbers, but pyada parasites do have a profound defect in oocyst development. Although there was a significant delay in implementing this aim, we are now on target to complete this aim by the end of the funding period.
Task 3 Test the effect of immucillins on the P. yoelii rodent malaria model.
1. Test whether the immucillins with best in vitro activity or best malaria-specific activity can cure mice with malaria. Year 1-2 2. Test whether effective immucillins are effective against transgenic P. yoelii that carry PfPNP. Year 3 3. Compare effects of malaria specific immucillins to immucillins that inhibit only mouse PNP or inhibit both PNPs in wild-type and parasites with disruption in purine salvage genes. Year 3
Earlier in our funding period, we tested Immucillin-H, DADMe Immucillin-H, MTImmucillin-H, and MT-coformycin against P. yoelii and P.berghei. Each of these inhibitors are able to kill cultured P. falciparum (Ting et al, and Madrid, Ting & Kim, unpublished). Unfortunately, none are able to cure mice. MT-ImmH, an inhibitor with 112-fold specificity for P. falciparum PNP, gave the best results with delay to death in some experiments. MTcoformycin is >20,000 more specific for PfADA over human ADA but was not efficacious although it has activity on cultured P. falciparum (Madrid, Ting and Kim, unpublished).
In related studies completed by our group (but not funded by this grant), we have disrupted Pfpnp and shown this renders pfpnp parasites less sensitive to MT-ImmH and much more sensitive to human PNP inhibitors. The pfpnp parasites, like pypnp parasites, are viable but attenuated at physiological concentrations of purines. Thus we have validated PNP as the major target of immucillins.
Because of these studies, we questioned whether the rodent malaria enzymes were as sensitive to the inhibitors as their P. falciparum orthologues. Therefore we cloned and fully characterized the rodent malaria PyPNP and PyADA (See alignments provided in 2007 progress report). Recombinant PyPNP was compared to PfPNP and its enzyme kinetics and inhibition profile are identical to that of PfPNP. Thus the inability of immucillins to cure mice infected with P. yoelii is not likely due to differences in the target PNP enzymes. Now that we have resolved some of the technical difficulties, we are finishing the constructs to replace PyPNP with PfPNP (#2 in this task). We have now mapped the key residues responsible for the methylthiospecificity of PfPNP by taking advantage of the finding that TgPNP is homologous to PfPNP but does not have activity against methylthiopurines (Chaudhary et al). We were able to determine that mutations in 3 key residues: V66I, V73I, Y160F were needed loss of MTI activity. The level of activity against MTI is 3 orders of magnitude less than wild-type and not biologically relevant.
We have also obtained the crystal structure of the triple mutant PfPNP with ImmH. This structure is now being refined and compared to the structure obtained earlier for PfPNP (Shi et al) . The key findings to date reveal that 3Mut PfPNP has a more crowded pocket than WT PfPNP. While individually the Val66Ile and the Val73Ile have minimal effects, together they cause crowding of the pocket makes the methylthio group unable to fit easily. The OH group of the Tyr 160 stabilizes the hydrophobic pocket by hydrogen bonding with water molecules. Pocket residue placement is more flexible without the hydroxyl group due to Tyr160Phe mutation, further constraining the MTI pocket. We hope to compare this crystal to one in which 3Mut PfPNP is crystallized with MT-ImmH. We will replace PyPNP with PfPNP with wild-type enzyme as well as with the triple mutant only activity against inosine to test the importance of the unique methylthiopurine substrate specificity for viability of Plasmodium parasites. Viability will be compared to parasites lacking pypnp. If the purine recycling activity of PNP is critical, the PNP mutant with activity against only inosine will be attenuated compared with the PfPNP wild-type transfectant.
Task 4 Test immucillins in combination with antimalarials
1. Establish dose response of agents (DFMO, deoxycoformycin, atovoquone, mycophenolic acid) against P. yoelii. Years 2-3 2. Test additive and synergistic effects of agents (particularly polyamine and ADA inhibitors) with best immucillin(s). Year 3-4 3. Test best drug combination for "causal" prophylaxis and cure after sporozoite challenge using P. yoelii sporozoites. Year 4
Dose response studies for agents to be used in combination were initiated. Because the immucillins were not effective in the rodent models we shifted our focus to verifying that recombinant enzyme targets were susceptible (see above). Previous studies reveal that the immucillins are bioavailable in mice. It seems probable that there are differences in purine metabolism between mice and humans that may make the rodent model less optimal for use evaluating purine salvage enzymes as drug targets. figure above) . Luciferase activity is proportional to parasitemias and can be detected in the liver at day 2 after infection (See figure below). We are completing pilot studies to test antimalarials against the liver stages. So far, as expected, atovoquone reduces liver luminescent signal but chloroquine is not effective against EEFs, but we are now repeating experiments to look at the reproducibility of our assays. Two other manuscripts have been submitted.
Conclusions:
Transfection studies are consistent with the hypothesis that PNP is important to viability of malaria parasites in vivo. Parasites lacking PyPNP are attenuated in blood stages, and have dramatically reduced development of oocysts. In addition, the attenuated blood stage parasites are protective against subsequent lethal challenge with P. yoelii. Attempts to disrupt ADA have finally been successful using a new technique for PCR mediated double homologous recombination, and preliminary studies suggest these parasites are unable to form oocysts. We have mapped the residues in PNP critical for methylthio activity and will genetically test the importance of the purine recycling activity of PNP. We have developed GFP-luciferase reporter parasites that are able to complete the entire life cycle and can be visualized during intrahepatic infection. These parasites are likely to be useful for development of in vivo and in vitro protocols for drug testing of antimalarials for erythrocytic and extraerythrocytic forms. Plasmodium species, the causative agents of malaria, are the most deadly members of the apicomplexan phylum. As with other members of the Apicomplexa, Plasmodium has a multifaceted life cycle encompassing an asexual phase within the intermediate host and a sexual cycle in the mosquito.
Gametocytogenesis and gametogenesis consist of an ensemble of processes leading to the differentiation of erythrocytic forms of the parasite into male or female gametocytes. These complex and coordinated steps insure the transmission of the parasite to the invertebrate host and are required for transmission of malaria to mammalian hosts. Gametocytes form in mammalian host, are taken up by the mosquito during a blood meal, transform into gametes in the mosquito midgut and then fuse to form a zygote. Zygotes differentiate into ookinetes which penetrate the midgut wall and differentiate into oocysts, in which sporozoites will develop.
Starting from the well controlled vertebrate milieu, the parasite must adapt to the mosquito environment where temperature fluctuates and nutrients are limited. Gametocytogenesis requires growth arrest and a differentiation step that will prepare the parasite for these changes. Sexual differentiation is accompanied by a tightly controlled gene expression program during which approximately 200-300 mRNAs are specifically expressed or predominantly expressed in sexual forms of the parasite (1-4). Transcriptional control of gene expression is implicated as a crucial step during this process with sex-specific transcript expression in gametocytes controlled by the sequences in the 5 flanking regions (5).
For some sexual stage genes posttranslational processes mediate gene expression. The genes coding for P25 and P28 ookinete proteins (PY00522 and PY00523 respectively) are transcribed at the gametocyte stage but their translation is delayed until the gamete and zygote stages (6) . A group of mRNAs with a common 3 UTR motif are specifically transcribed at the gametocyte stage but their translation is repressed until the parasite requires the presence of the proteins they encode (4) . Recently an RNA helicase called DOZI (7) was identified in P. berghei that participates in the storage and translation repression of a large number of transcripts. Therefore, sexual differentiation in Plasmodium requires fine tuning of both transcriptional and post-transcriptional processes to regulate gene expression.
The mechanisms controlling the transition from the asexual erythrocytic stage into a gametocyte-specific gene expression program are unknown. Initial analysis of the genomes of Plasmodium species revealed few canonical transcriptional regulators (8) . On the other hand, the RNA polymerase II machinery (9) is conserved within Apicomplexa and chromatin modification plays an important role in gene regulation (10) . The finding that certain DNA motifs are recurrent in the promoters of Apicomplexa and bind to nuclear factors (11) (12) (13) suggests that unrecognized transcription factors exist. Recently, a novel family of AP2 domain plant-like transcription factors was identified in the genomes of the Apicomplexa (14) . In plants these transcription factors bind to specific DNA motifs and regulate a variety of biological responses (15) , but the function of apicomplexan AP2 proteins has not been experimentally validated.
Two proteins containing a high mobility group box (HMGB) are highly conserved among Plasmodium species (16) . HMGB box proteins are small transcriptional regulators that bind DNA in a non-sequence specific fashion and bend it, leading to the recruitment of RNA polymerase II and the induction of transcription (17) . HMGB proteins also actively participate in chromatin remodelling by increasing nucleosome sliding and accessibility of the chromatin (17) . The two P. falciparum HMGB proteins, HMGB1 (PFL0145c) and HMGB2 (MAL8P1.72), have the biochemical characteristics of the HMGB box family of transcriptional regulators (16) . Interestingly, these HMGB are differentially expressed. HMGB1 is expressed during the erythrocytic asexual cycle whereas HMGB2 is slightly expressed at the schizont stage and highly expressed at the gametocyte stage (2, 16) .
In this study, we evaluated the role of the HMGB2 protein in regulation of sexual stage gene expression. We disrupted hmgb2 in the rodent malaria model Plasmodium yoelii and investigated its function in vivo in its two hosts: the mouse and the mosquito Anopheles stephensi. Our results indicate that PyHMGB2 plays a central and conserved role in regulating gene expression during the sexual cycle of Plasmodium.
Experimental Procedures
Plasmodium yoelii life cycle.
P. yoelii YM lethal strain was maintained in naïve BALB/c or Swiss Webster mice. For mosquito infection experiments 4-5-day-old A. stephensi were fed for 15 min on anesthetized Swiss Webster mice infected with either wild-type (WT) or pyhmgb2 (KO) P. yoelii parasites. Prior to feeding, the abundance and the sex ratio of the gametocyte-stage parasites was checked on Giemsa stained blood smears. At day 7 postinfection, midguts were monitored for infection and oocysts were counted by either counting fluorescent GFP-positive KO parasite oocysts (see below) or after mercurochrome staining (WT and KO parasite lines). Salivary glands from mosquitoes on day 14 or 15 post-infective blood meal (p.i.) were dissected to recover sporozoites.
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Exflagellation experiments were performed as described in (18) and exflagellation centers were counted at 9 mins post induction. Male and female gametocytes were identified by morphology on Giemsa smears. In vitro culture of ookinetes was performed as described in (19) . Ookinete numbers were counted with a hemacytometer under phase-contrast microscope and normalized to the original gametocyte content of the culture. Statistical analysis was performed using an un-paired t-test available using the GraphPad Prism software package (GraphPad software, San Diego, CA, USA).
P. yoelii transfection, plasmid construction and genotyping
A fragment of the pyhmgb2 gene (PY07077) amplified from YM strain genomic DNA using the following primers (5'-ggatccATTACATGTTATGATCTTCTAC-3' and 5'-gcggccgc-CAATGCTCTCTTTGGAGCTAATG-3') was inserted into the pMD205-GFP vector in the BamH1 and NotI restriction sites. A SpeI restriction site was created by site directed mutagenesis (Stratagene, La Jolla, CA, USA) at nucleotide position 258 of the cloned fragment (position 3152 of the MALPY02526 contig sequence) using the following primer (5'-TACAACTTTAGAACAAGACTAGTACTG TTTTGAAACAACTCA-3').
Prior to transfection, the targeting plasmid was linearized using a SpeI site created in the pyhmgb2 open reading frame. Transfections were performed as described in (20, 21) . Cloning was performed after limiting dilution and infection of 20 BALB/c mice. A WT non recombinant clone was passaged in parallel with KO clones so that mouse and mosquito passage numbers were comparable for all experiments.
Diagnostic PCR was performed using the primers T7 (5'-TAATACGACTCACTATAGGG-3') and A (5'-ATCGATTAGTAGAATATGTAATATA-3') as indicated in Figure 1 . A probe containing a portion of the pyhmgb2 gene was amplified by PCR and digoxigeninlabeled (DIG) using the DIG random prime labeling kit (Roche Applied Science, Indianapolis, IN, USA). Southern blot was performed after running 1 μg of HindIII digested genomic DNA on a 0.8 % agarose gel and passive transfer on a nylon membrane and revealed using an anti-DIG antibody coupled to peroxidase (Roche Applied Science, Indianapolis, IN, USA).
Infectivity and survival assays.
Five BALB/c or Swiss Webster mice per group were infected intravenously using 5x10 5 and 1x10 6 parasites respectively. Beginning twenty-four hours after injection a thin smear of blood was prepared daily and stained with Giemsa reagent. For each sample, at least 1000 RBCs were examined by microscopy, and the percentage of parasitized erythocytes was calculated. Mouse viability was monitored every 12 hours. Statistical analysis was performed using the GraphPad Prism software (GraphPad software, San Diego, CA, USA).
Microarray design and experiments
Two mice per group were infected with one million purified schizonts from the WT and two clones (B3 and D1) of the pyhmgb2 lines. When parasitemia reached 10 to 20 % and equivalent gametocytemia, total RNA was extracted from the WT and the B3 and D1 clones of the KO parasite lines using the Trizol method on saponin lysed parasites. For each group, RNA originating from the two mice was pooled. Total RNA integrity was checked using the Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) at the AECOM shared sequencing facility.
P. yoelii microarrays were produced in the Molecular Genomics Core Facility, Drexel University College of Medicine under the direction of L.W.B. The spotted microarray contained 7,080 65mer oligonucleotides (probes). Each probe was spotted twice on the array. The array has been developed and previously evaluated with hybridizations of total RNA extracted from blood stages. Probe sequences were blasted against annotated P. yoelii genes downloaded by on April 29, 2008 www.jbc.org Downloaded from from PlasmoDB (version 5.2). In total, 6,451 probes were specifically mapped to 6,428 annotated P. yoelii genes with a perfect match (22) .
To prepare each probe, 10 μg of P. yoelii RNA was reverse transcribed into cDNA in the presence of aminoallyl-dUTP (FairPlay microarray labeling kit; Stratagene, La Jolla, CA). The cDNA was then fluorescently labeled by reaction with monofunctional, normal Nhydroxysuccinimide-activated Cy3 or Cy5 dye (Amersham Biosciences Inc., Piscataway, NJ). The Cy dye-labeled cDNA was purified, and the yield and specific activity of each probe were determined by absorption spectroscopy. Pairs of Cy3-and Cy5-labeled probes were pooled and hybridized to the P. yoelii microarrays for 14 to 16 h at 60°C in a 60-μl mixture.
Following hybridization and washing, slides were scanned using a GenePix 4000A microarray laser scanner (Axon Instruments Inc., Union City, CA), and the fluorescence intensity of each DNA feature was determined at 532 nm (Cy3) and at 635 nm (Cy5). Data for each gene were obtained from replicate features (n = 2). On a second set of arrays the assignments of Cy3 and Cy5 for labeling of the paired cDNA probes were reversed (standard dye flip). Gene expression data were acquired and analyzed using the GenePixPro 5.0 and Acuity 3.0 Microarray Informatics software (Axon Instruments). Two biological replicates with the proper dye swap controls were performed resulting in a total of 8 hybridization signals from each parasite line for each gene represented on the microarray. Data have been deposited to GEO database (GXXXX) together with the microarray platform (GPL5381).
Microarray normalization and statistical analysis
The .gpr files were loaded using the Bioconductor limma package. Quality assessment of the microarrays was performed using the package arrayQuality. The data was then normalized in order to remove systematic technical variation. Two-channel normalization was performed using the function maNorm in the package marray.
Three types of normalization were performed: (i) using the median enabling global median location normalization; (ii) using a global normalization using the scatter-plot smoother loess; (iii) a 2 dimension spatial normalization using the loess function. Selection of differentially expressed genes was performed using the package limma that is based on the fitting of the expression data for each (24) . A p-value cut-off to 0.05 was set leading to a false discovery rate of 5 %.
RT-PCR and real time quantitative RT-PCR
One microgram of DNase treated total RNA was utilized to produce cDNA following the instructions of the first strand cDNA kit (Invitrogen) with oligo dT as a primer. PCR was performed during 30 cycles using the following primers: pyada forward (5'-ATGATGGAAATTCCAACTGAAGA-3'), pyada reverse (5'-TTAAAAGTACAACGCTTTAAGCTCG-3'), pyhmgb2 forward (5'-CCTATCAAGTGTGTTGTATATGTCTTC-3') and pyhmgb2 reverse (5'-TCTTCTATTTCTTTGGAATAACGAAC-3'). Real time quantitative PCR was performed on the 7300 ABI apparatus using the Power Sybr (Applied Biosystems, Foster City, CA) mastermix in a 20 μL volume according to the manufacturer's instructions. PCR primers were designed using the Primerexpress software (Applied Biosystems, Foster City, CA) to amplify regions of 100-150 nt. Each experiment was performed at least two times in duplicate. A list of other primers used for verification of microarray results by real-time quantitative RT-PCR is available in supplementary materials.
Western Blotting.
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Ookinete cultures of WT and KO parasites containing a similar number of ookinetes (approximately 1x10 6 ) were harvested by centrifugation and extracted with SDS-PAGE loading buffer. The extracts were size fractionated on SDS-12% polyacrylamide gels and proteins were transferred to polyvinylidene difluoride membrane . The membrane was incubated over-night at 4ºC with mouse monoclonal anti-Pys21 (also named Pys25) and anti-Pys25 (also named Pys28) antibodies (A gift from Dr. T. Tsuboi, Ehime University, Japan;(25)) diluted 1/500 and an anti-PyADA antibody diluted 1/1000 in a PBS-5% milk solution. The membrane was then incubated 1 hour at room temperature with a 1:10,000 dilution of peroxidaseconjugated anti-mouse antibody. After extensive washing, signal was revealed using a chemiluminescent substrate, according to the manufacturer's instructions (ECL, AmershamPharmacia Biotech). Relative amounts of proteins were determined by densitometry using the Quantiscan software (Densylab, Microvision Instruments, Evry, France). Relative expression of Pys25 and Pys28 in wild-type and KO was normalized by comparing the level of expression of the PyADA protein in each sample.
Results

Disruption of the pyhmgb2 locus
Disruption of the pyhmgb2 locus was performed after integration of a plasmid containing a segment of the pyhmgb2 gene and the selectable marker cassette PbDHFR-TS fused to the GFP gene. The integration of this plasmid at the pyhmgb2 locus created two copies of the truncated gene after a single cross-over event (Fig.1A) . Two independent pyhmgb2 knock-out clones ( pyhmgb2; clones B3 and D1) were verified by PCR of genomic DNA (Fig.1B and data not shown) and Southern Blot using a pyhmgb2 gene probe (Fig.1C) . Disruption of the pyhmgb2 locus resulted in a total loss of detectable pyhmgb2 transcript expression by RT-PCR for the two clones (Fig 1D and data not shown) while the transcript of an unrelated gene [pyada (PY020760) Fig 1D, right panel] was not affected. Real time quantitative RT-PCR also confirmed that no residual expression of pyhmgb2 gene could be detected.
The PyHMGB2 KO parasites are slightly attenuated during the asexual erythrocytic cycle.
We studied the effect of the disruption of the pyhmgb2 locus on the asexual erythrocytic stage by examining growth of the parasite ( Fig. 2A) as well as survival curves of mice infected by the WT or the pyhmgb2 parasite strains (Fig. 2B ). pyhmgb2 parasite strains were able to proliferate normally and parasitemia was readably detectable after day 4. However, there was a delay in the onset of parasitemia in the pyhmgb2 infected mice when compared to the WT parasite strain ( Fig.  2A ) and the mice infected by the pyhmgb2 parasite strains survived longer, dying at days 8-9 post infection whereas mice infected with the WT parasite strain died 6-8 days after infection (Fig. 2B) . The delay in the onset of parasitemia and the change in the kinetics of death of the mice were reproducible in experiments with both BALB/c and Swiss Webster mice (data not shown).
The pyhmgb2 parasites form gametocytes and ookinetes.
We examined whether the pyhmgb2 parasites could complete the sexual cycle. The number of gametocytes on Giemsa stained blood smears was similar in mice infected with pyhmgb2 parasite strains compared to the WT parasite after 2 days of infection (Table I ). There were no significant differences in the level of mature gametocytes between the pyhmgb2 parasite strains and the WT. The parasites were able to undergo gametocyte exflagellation (Table I) , but pyhmgb2 strains produced a decreased number of ookinetes when compared to the WT (Table I) .
The pyhmgb2 parasites have dramatically impaired oocyst production.
We fed mosquitoes on mice infected with pyhmgb2 and WT parasite strains bearing similar numbers of gametocytes and asexual stages. Eight days after feeding, by on April 29, 2008 www.jbc.org Downloaded from mosquito midguts were dissected and the number of oocysts scored using light microscopy. The number of infected mosquitoes for each strain was similar in each experiment (Table II) . In three independent experiments, the mean number of oocysts per pyhmgb2-infected mosquito was approximately 10 % of the mean oocyst number seen in WT parasite infected mosquitoes (Table II) . The oocysts produced by pyhmgb2-infected mosquitoes were able to complete the life cycle and produce viable sporozoites that were infectious to mice. The blood of the mice infected by those sporozoites was collected one week after infection. Using real time quantitative PCR we showed that these parasites do not express the pyhmgb2 transcript and have the same genotype as the pyhmgb2 parent (data not shown), indicating that no reversion of the disrupted allele had occurred.
Microarray comparison of pyhmgb2 and wildtype gene expression.
To examine the global expression profile of pyhmgb2 parasites, we compared the transcriptome of pyhmgb2 to the WT strain using a long oligonucleotide microarray designed to represent all the annotated genes of P. yoelii. These arrays have been previously validated to accurately reflect blood stage and liver stage P. yoelii gene expression (22, 26) . We harvested total RNA from a mixture of synchronized late erythrocytic stage parasites with similar numbers of gametocytes. Two independent clones of the pyhmgb2 parasites were compared to the WT strain. Of the 6,428 annotated P. yoelii genes spotted on the array, only 32 genes showed differential expression in the KO (Table III) . It is interesting to note that we found only downregulated genes in the pyhmgb2 parasites. There was no detectable difference in expression of the transcript for Pyhmb1 (PY05184).
The differential expression of 10 downregulated genes was independently confirmed by real time quantitative RT-PCR (Figure 3) . We also confirmed, by real time quantitative RT-PCR, that the transcript coding for the PyHMGB1 (PY05184) protein was not differentially expressed, suggesting that compensation by the overexpression of another HMGB did not occur in the pyhmgb2 parasites. Among control genes analyzed by qRT-PCR were those with ubiquitous expression [pyada (PY02076) or pytubI (PY01155); Fig. 3 and Supp. Fig 1] and other known gametocyte-specific genes whose expression was not altered by microarray analysis [ Fig. 3 and Supp. Fig 1] . These were expressed at similar levels in WT and pyhmgb2 parasites, confirming that the differences found by microarray profiling were not due to discrepancies in the number or maturity of asexual parasites and/or gametocytes present in the WT and pyhmgb2 samples.
Down-regulated genes in the pyhmgb2
parasites are conserved and expressed at the gametocyte stage.
Among the genes down-regulated in the pyhmgb2 parasite, we found P. yoelii homologues of the P25 and P28 ookinete genes (PY00522 and PY00523 respectively) and of PfCCp2 (PY01580; also named lap4 in P. berghei) that have a critical importance in oocyst development (27, 28) . Of the 32 genes, all but three were conserved among all Plasmodium species (Table III and Supp.  Table I ). Over 92 % of these genes are specifically expressed at the gametocyte stage or show enhanced expression at the gametocyte stage (Fig. 4) . Transcripts of two P. falciparum homologues of down-regulated P yoelii genes (PY06201 and PY02893) are exclusively expressed at the asexual stage (Fig. 4) .
We compared the steady state transcript levels in purified WT gametocytes and asexual erythrocytic forms for 10 of the genes down-regulated in the pyhmgb2 by real-time quantitative RT-PCR (Fig. 5) . As shown for its P. falciparum (29) and P. berghei homologues (4), the pyhmgb2 transcript is over-expressed (8-fold) in gametocytes compared to asexual stages (Fig.  5) . We confirmed that 8 of the down-regulated genes in the pyhmgb2 parasites were specifically expressed or over expressed at the gametocyte stage in WT P. yoelii (Fig. 5 ). Analogous to its P. falciparum homologue, the by on April 29, 2008 www.jbc.org Downloaded from PY02893 transcript (adenosylhomocysteinase) is not overrepresented in gametocytes. Similarly, pyada transcript level was equivalent in gametocyte and asexual parasite extracts.
The peak of expression of the Pfhmgb2 transcript precedes or overlaps those of the down-regulated genes in the pyhmgb2 parasites.
We queried available expression profile data for gametocytogenesis of the P. falciparum 3D7 strain (3) for pfhmgb2 and other orthologues of genes down-regulated in the pyhmgb2 parasites (Supp. Figure 2 and Table III ). The pfhmgb2 transcript expression peaks between day 6 and day 8 of the gametocytogenesis of 3D7 strain, while the genes downregulated in the pyhmgb2 parasites peak at day 8 ( Supplementary Fig. 2 and Table III) . Interestingly, the signal yielded by the oligonucleotides representing the two genes expressed exclusively at the asexual stage (Table III) does not follow this pattern (data not shown). These data are consistent with the hypothesized role of PyHMGB2 in the transcriptional regulation of the downregulated genes.
Genes downregulated in the pyhmgb2 parasites encode proteins expressed at the ookinete stage.
Translational repression during Plasmodium sexual development is described as a major mechanism of gene regulation. We examined the proteomic data (4,30) available for the genes whose expression was downregulated in the pyhmgb2 parasites. Of the 18 genes transcripts down-regulated in the pyhmgb2 parasites for which proteomic data is available, 16 (88%) had mRNA expressed at the gametocyte stage but only 5 had protein detectable in gametocytes (including 4 with both gametocyte and ookinete protein expression). Twelve of the 18 genes (67%; all with mRNA expressed in gametocytes stages) had gene products detected in only ookinetes or oocysts (Table III) . Interestingly, more than 80% of the genes downregulated in the pyhmgb2 parasites had their expression reduced by at least 2 fold in the DOZI parasites (7) (Suppl. Table S1 ).
We performed an analysis of the expression of the PY00522 and PY00523 proteins, homologues of the P. falciparum Pfs25 and Pfs28 proteins. A similar number of in vitro cultured ookinetes from WT or pyhmgb2 parasites was loaded on a polyacrylamide gel, separated by electrophoresis and subjected to Western Blot. As shown in figure 6A , the expression of PyADA (upper panel), was comparable in WT and KO, whereas the pyhmgb2 parasites expressed approximately 3-4 fold less Pys25 and Pys28 protein as quantified by densitometry (Fig. 6B) in concordance with the trancriptomic data. An IFA performed on the pyhmgb2 parasites in vitro cultured ookinetes did not reveal a subpopulation with expression of these two proteins at the WT level (data not shown).
Discussion
In this study, we investigated the role of the PyHMGB2 during the complete life cycle of the malaria parasite P. yoelii. HMGB1 and HMGB2 are highly conserved among Plasmodium species (16). The P. falciparum homologue of the PyHMGB2 protein is expressed by schizonts at the end of the erythrocytic asexual cycle and exhibits enhanced expression during gametocytogenesis (29) . P. yoelii homologues follow the same pattern of expression as confirmed by real-time quantitative RT-PCR data (Fig.5) .
Loss of expression of the pyhmgb2 transcript during the erythrocytic asexual cycle in the mouse resulted in the delay of the onset of the parasitemia and time to death for the mice infected by the KO strains (Fig 2) . Although pyhmgb2 parasites are attenuated, PyHMGB2 is not essential during the asexual cycle of the parasite. The mild phenotype in asexual stages may be due to functional redundancy of PyHMGB2 with PyHMGB1 (16), but pyhmgb2 parasites did not compensate with over-expression of the pyhmgb1 transcript (Fig. 4) .
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Analysis of the pyhmgb2 parasite transcriptome (Table III) revealed downregulation of a subset of gametocyte transcripts. Two down-regulated genes, P. yoelii acid protease (PY06201) and adenosylhomocysteinase (PY02893) have P. falciparum orthologues exclusively expressed during the asexual cycle. The P. berghei homologue of the acid protease is expressed at the gametocyte stage indicating that this gene might be gametocyte-specific in rodent malarias (4) . The adenosylhomocysteinase (PY02893) transcript expression profile was confirmed by real-time quantitative PCR (Fig.  5) . P. berghei adenosylhomocysteinase protein is expressed in both asexual parasites and ookinetes ( (4); www.plasmodb.org), indicating a potential role of this gene during both asexual and sexual development.
The majority of the genes that are differentially expressed in the KO have a homologue in all the Plasmodium species sequenced to date. In contrast, only 50 % of the genes induced at the gametocyte stage for P. berghei have a homologue in P. falciparum (4) . Thus the genes whose expression is regulated by HMGB2 probably play conserved roles in all Plasmodium species.
The process of gametogenesis that is triggered in the mosquito after the blood meal is controlled by kinases that are able to rapidly induce a cascade of events in response to an external stimuli (31) . Interestingly, none of the genes for these kinases is differentially regulated in the pyhmgb2 parasites (Table  III ; Supp. Fig. 1) .
The number and the maturity of the gametocytes were similar between pyhmgb2 and the WT (Table I) suggesting that PyHMGB2 is not involved in the induction, commitment and establishment of the gametocytemia in the blood. Gametocyte exflagellation was also comparable in the pyhmgb2 parasite when compared to the WT. Ookinete formation was significantly decreased in pyhmgb2 and comparable to that found for a double knock-out of the P28 and P25 P. berghei genes (27, 32) . In vivo, we observed a drastic impairment of oocyst formation (Table II) , although our microarray data indicate that PyHMGB2 regulates expression of genes transcribed in gametocytes.
We confirmed the gametocyte specific expression of 9 genes down-regulated in the pyhmgb2 parasites, verifying concordance of the expression profiles in P. falciparum, P. berghei and P. yoelii. The P. berghei proteomic data suggest that many of these genes are translationally repressed until the ookinete stage (Table III) (4) . However, due to limitations in sensitivity of proteomic technology, we cannot rule out that some genes down-regulated in the KO are expressed in other stages of the life cycle.
Translational repression seems to be widespread during the sexual stages of Plasmodium (7) and has been well characterized for Pbs25 and Pbs28, two proteins whose transcript levels are downregulated in the KO (33) . In accordance with the proteomics data, 80% of the genes downregulated in the pyhmgb2 parasites (Supp . Table S1 ) have their expression at least partially controlled through the action of DOZI as shown by the microarray data collected for the P. berghei DOZI parasites (7) .
Three genes downregulated in the mutant parasites (Table III) have been disrupted in different Plasmodium species. The Pbs21 (or Pbs25) and Pbs28 genes, which encode surface proteins of ookinetes, have been shown to have redundant function as only a double KO exhibited a clear phenotype (27) . The P. berghei strain with double KO of Pbs21 and Pbs28 has modest reduction of ookinete production and a drastic impairment of oocyst production in the mosquito (27) . The ookinetes produced in the double KO are not able to cross the midgut epithelium, interact with the basal lamina and consequently do not produce oocysts (27) . Similarly, PfCcp2 (P. falciparum) and its orthologue pblap4 (P. berghei) have been disrupted with a phenotype in the oocyst stage despite protein expression at the gametocyte stage (28, 34) . The observation that Pys25, Pys28 and PyCCP2 genes are downregulated in our mutant could be sufficient to explain the phenotype of the pyhmgb2 parasite. Nevertheless, the other down-regulated genes could contribute to by on April 29, 2008 www.jbc.org Downloaded from ookinete and oocyst formation given their protein expression profile and conservation across Plasmodium species. For example 3 gametocyte specific articulins, a class of cytoskeletal proteins, are downregulated in the pyhmgb2 parasites suggesting involvement of articulins in the maintenance of stage-specific cellular shapes (35) .
The few oocysts generated by the pyhmgb2 were able to produce a reduced number of infective sporozoites (data not shown). The Pbs21 and Pbs28 double KO parasites were also able to produce infective sporozoites (27) . Therefore, PyHMGB2 appears to play a crucial role for the full expression of these genes but is not absolutely required.
Since the HMGB box family does not bind to DNA in a sequence-specific manner, PyHMGB2 is likely to be recruited to DNA by other factors or by a specific chromatin context (17) . Interestingly, yeast two hybrid interaction data (36) show that HMGB2 is in the center of a broader network of proteins potentially involved in transcription regulation including 3 AP2 domain plant-like transcription factors (Supplementary Figure  3) . AP2 proteins regulate the transcription of number of stress-induced pathways in plants (15) . Genes for AP2 family members in P. falciparum are differentially expressed at specific developmental stages implicating them in transcriptional regulation of stagespecific gene expression (14) . HMGB2 also interacts in yeast two hybrid with chromatin remodeling and modification enzymes like the acetyl-transferase GCN5 and a potential histone demethylase containing a Jumonji domain (36) (Supplementary Figure 3) . PyHMGB2 may act cooperatively with AP2 sequence specific transcription factors and the chromatin modification machinery to control gene expression.
The sexual cycle of Plasmodium is a critical process required for transmission of malaria via the mosquito. In this study, we demonstrate that PyHMGB2 is not required for asexual growth but is involved in controlling genes important for oocyst development in the mosquito. Analysis of gene expression, proteomic and protein interaction data indicate that PyHMGB2 plays a pivotal role in controlling the transcriptional expression of a set of genes that are crucial for completion of the sexual cycle of malaria. 
